🏦 TRC20-USDT Crypto Refund 2026 Claim Reward ⚡⚡ telegra.ph/COMPENSATION-05-12-9?hs=cbb4701c34e8bc3fcf8a0f8190a79609& 🏦
0pz770
MSCTR | Cancer Research |Translational Research
PhD from Indian Institute of Science with training from McGil University – Canada and MIT-USA during post doctoral studies Manjula has spent long years in the Industry. She is an expert in Biotherapeutics especially critical reagent and assay development (in vitro and in vivo) for regulatory submission of protein drugs. She also has established many companies, the latest being a consultancy firm named Beyond Antibody. Manjula with 20-years long market experience concentrates on translating basic research to products and processes for direct patient care in various areas of cancer.
>
0pz770
ezq0x8